Profil
Anne Champsaur worked as a Senior Director of Regulatory Affairs at ALZA Corp.
She then worked as an Executive Director of Drug Safety and Medical Affairs at CV Therapeutics, Inc. from 2004 to 2007.
Prior to that, she was the Director of Clinical Development and Medical Affairs at Pasteur Mérieux Connaught and the Deputy Head of Clinical Research and Regulatory at SangStat Medical Corp.
She also served as the Vice President of Drug Safety at Exelixis, Inc. and Jazz Pharmaceuticals, Inc. Dr. Champsaur holds a doctorate degree from Université Claude Bernard Lyon 1.
Ehemalige bekannte Positionen von Anne Champsaur
| Unternehmen | Position | Ende |
|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
| Pasteur Mérieux Connaught | Technik-/Wissenschafts-/F&E-Leiter | - |
| SangStat Medical Corp. | Corporate Officer/Principal | - |
Ausbildung von Anne Champsaur
| Université Claude Bernard Lyon 1 | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| SangStat Medical Corp. | Health Technology |
| Pasteur Mérieux Connaught | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
